Segment Information by Division
January 1 to December 31
|
|
|
||||||||||||||||||
€ million |
|
Silicones |
|
Polymers |
|
Biosolutions |
|
Polysilicon |
|
Other |
|
Consolidation |
|
Group |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
External sales |
|
2,599.0 |
|
1,653.3 |
|
296.4 |
|
1,529.8 |
|
129.0 |
|
– |
|
6,207.5 |
||||||
Internal sales |
|
0.1 |
|
20.3 |
|
– |
|
– |
|
– |
|
-20.4 |
|
– |
||||||
Total sales |
|
2,599.1 |
|
1,673.6 |
|
296.4 |
|
1,529.8 |
|
129.0 |
|
-20.4 |
|
6,207.5 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
EBIT |
|
421.0 |
|
198.7 |
|
20.7 |
|
528.9 |
|
-34.2 |
|
-0.8 |
|
1,134.3 |
||||||
Depreciation, amortization and (reversals of) impairments |
|
131.9 |
|
53.9 |
|
17.9 |
|
127.8 |
|
72.7 |
|
– |
|
404.2 |
||||||
EBITDA |
|
552.9 |
|
252.6 |
|
38.6 |
|
656.7 |
|
38.5 |
|
-0.8 |
|
1,538.5 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
EBIT includes: result from investments in joint ventures and associates |
|
3.9 |
|
– |
|
– |
|
– |
|
58.5 |
|
– |
|
62.4 |
||||||
Impairment of fixed assets |
|
-0.7 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
-0.7 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Asset additions1 |
|
143.2 |
|
100.1 |
|
33.5 |
|
30.6 |
|
36.4 |
|
– |
|
343.8 |
||||||
Additions to financial assets |
|
– |
|
– |
|
– |
|
– |
|
0.3 |
|
– |
|
0.3 |
||||||
Asset additions |
|
143.2 |
|
100.1 |
|
33.5 |
|
30.6 |
|
36.7 |
|
– |
|
344.1 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Assets (Dec. 31) |
|
1,955.7 |
|
980.2 |
|
332.9 |
|
972.0 |
|
3,893.7 |
|
-0.2 |
|
8,134.3 |
||||||
Liabilities (Dec. 31) |
|
996.1 |
|
538.8 |
|
122.1 |
|
583.5 |
|
2,793.9 |
|
-0.5 |
|
5,033.9 |
||||||
Net assets (Dec. 31) |
|
959.6 |
|
441.4 |
|
210.8 |
|
388.5 |
|
1,099.8 |
|
0.3 |
|
3,100.4 |
||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
|
49.3 |
|
– |
|
– |
|
– |
|
659.6 |
|
– |
|
708.9 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Research and development expenses |
|
64.7 |
|
35.1 |
|
5.6 |
|
21.3 |
|
37.5 |
|
– |
|
164.2 |
||||||
Employees (Dec. 31) |
|
5,211 |
|
1,595 |
|
751 |
|
2,219 |
|
4,630 |
|
– |
|
14,406 |
||||||
Employees (average) |
|
5,157 |
|
1,591 |
|
742 |
|
2,195 |
|
4,667 |
|
– |
|
14,352 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
External sales |
|
2,243.8 |
|
1,282.1 |
|
246.1 |
|
792.2 |
|
128.0 |
|
– |
|
4,692.2 |
||||||
Internal sales |
|
0.2 |
|
16.4 |
|
– |
|
– |
|
– |
|
-16.6 |
|
– |
||||||
Total sales |
|
2,244.0 |
|
1,298.5 |
|
246.1 |
|
792.2 |
|
128.0 |
|
-16.6 |
|
4,692.2 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
EBIT |
|
276.8 |
|
229.3 |
|
21.6 |
|
-147.8 |
|
-117.6 |
|
0.5 |
|
262.8 |
||||||
Depreciation, amortization and (reversals of) impairments |
|
111.0 |
|
41.2 |
|
16.5 |
|
152.5 |
|
82.3 |
|
– |
|
403.5 |
||||||
EBITDA |
|
387.8 |
|
270.5 |
|
38.1 |
|
4.7 |
|
-35.3 |
|
0.5 |
|
666.3 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
EBIT includes: result from investments in joint ventures and associates |
|
3.4 |
|
– |
|
– |
|
– |
|
31.5 |
|
– |
|
34.9 |
||||||
Impairment of fixed assets |
|
-0.6 |
|
– |
|
– |
|
-0.1 |
|
-0.3 |
|
– |
|
-1.0 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Asset additions1 |
|
96.9 |
|
35.6 |
|
19.9 |
|
24.9 |
|
47.1 |
|
– |
|
224.4 |
||||||
Additions to financial assets |
|
– |
|
– |
|
– |
|
– |
|
0.4 |
|
– |
|
0.4 |
||||||
Asset additions |
|
96.9 |
|
35.6 |
|
19.9 |
|
24.9 |
|
47.5 |
|
– |
|
224.8 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Assets (Dec. 31) |
|
1,644.3 |
|
673.5 |
|
223.1 |
|
1,040.8 |
|
3,368.9 |
|
-0.1 |
|
6,950.5 |
||||||
Liabilities (Dec. 31) |
|
955.4 |
|
390.7 |
|
109.7 |
|
577.9 |
|
3,225.0 |
|
– |
|
5,258.7 |
||||||
Net assets (Dec. 31) |
|
688.9 |
|
282.8 |
|
113.4 |
|
462.9 |
|
143.9 |
|
-0.1 |
|
1,691.8 |
||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
|
45.0 |
|
– |
|
– |
|
– |
|
554.5 |
|
– |
|
599.5 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Research and development expenses |
|
60.2 |
|
32.2 |
|
5.7 |
|
21.3 |
|
37.2 |
|
– |
|
156.6 |
||||||
Employees (Dec. 31) |
|
5,076 |
|
1,540 |
|
764 |
|
2,180 |
|
4,723 |
|
– |
|
14,283 |
||||||
Employees (average) |
|
5,087 |
|
1,555 |
|
756 |
|
2,239 |
|
4,764 |
|
– |
|
14,401 |
||||||
|
||||||||||||||||||||
